| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
672 |
533 |
$23K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
52 |
44 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
51 |
48 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
44 |
39 |
$2K |
| 99188 |
|
176 |
129 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
45 |
34 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
23 |
12 |
$549.09 |
| 90670 |
|
76 |
58 |
$512.46 |
| 90698 |
|
33 |
30 |
$432.60 |
| 90686 |
|
38 |
24 |
$185.40 |
| 90680 |
|
17 |
14 |
$170.82 |
| 94760 |
|
15 |
12 |
$28.60 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
150 |
45 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
357 |
266 |
$0.00 |
| 90461 |
|
160 |
138 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
15 |
13 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
54 |
26 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
20 |
15 |
$0.00 |
| 96161 |
|
42 |
35 |
$0.00 |